Summary:
Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Dermatology Solutions on 4/2/2026 to 4/6/2026. The laboratory was surveyed under 42 CFR Part 493 CLIA requirements. Standard deficiencies cited are as follows: D3011 FACILITIES CFR(s): 493.1101(d) Safety procedures must be established, accessible, and observed to ensure protection from physical, chemical, biochemical, and electrical hazards, and biohazardous materials. This STANDARD is not met as evidenced by: Based on record review and email interview, safety procedures failed to be observed to ensure protection from chemical hazards from 10/16/2025 to 4/2/2026. Findings included: 1. The Ventilation and Fume Hood Use for Staining Reagents procedure was approved by the Laboratory Director on 10/16/2025. Badge monitoring of chemical exposure was to be quarterly or sooner if changes in process or reagents occurred. The Ventilation and Fume Hood Use for Staining Reagents procedure under responsibility, indicated the Laboratory Director was to review monitoring reports, sign/date, and implement